☆ 4.6 Article

Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study

GYNECOLOGIC ONCOLOGY (2023)

Get Full Text
Add to Collection

Journal

GYNECOLOGIC ONCOLOGY
Volume 171, Issue -, Pages 141-150

Publisher

Elsevier BV
DOI: 10.1016/j.ygyno.2023.01.010

Keywords

-

Categories

Obstetrics & Gynecology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.